Trials / Completed
CompletedNCT02432742
Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds
A Randomised, Multi-center, Evaluator-blinded Study in China to Evaluate the Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of using Restylane Perlane compared to Restylane for correction of moderate to severe nasolabial folds (NLF) in a Chinese population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Perlane | Intradermal injection |
| DEVICE | Restylane | Intradermal injection |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-03-01
- Completion
- 2016-08-01
- First posted
- 2015-05-04
- Last updated
- 2022-08-26
- Results posted
- 2020-12-23
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02432742. Inclusion in this directory is not an endorsement.